Cost-effectiveness of licensed treatment options for restless legs syndrome in the UK and Sweden

By Lees M.   Roberts G.   Tabberer M.   DasGupta R.   Finnern H. W.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2919-2930

Informa Healthcare

Access to resources Recommend Favorite

The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden

By Zethraeus N.   Ström O.   Borgström F.   Kanis J.   Jönsson B.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden

By Bernfort Lars   Sennfält Karin   Reichard Olle  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 6-7, 2006-07 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïïve human immunodeficiency virus-1 patients in Sweden

By Thuresson Per-Olof   Heeg Bart   Lescrauwaet Benedicte   Sennfäält Karin   Alaeus Annette   Neubauer Aljoscha  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 4, 2011-04 ,pp. : 304-312

Informa Healthcare

Access to resources Recommend Favorite

A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden

By Fredrikson Sten  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 756-762

Informa Healthcare

Access to resources Recommend Favorite